↓ Skip to main content
What is this page? Embed badge

Sandostatin® in the Treatment of Acromegaly

Overview of attention for book
Cover of 'Sandostatin® in the Treatment of Acromegaly'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Clinical Aspects of Growth Hormone Hypersecretory States
  3. Altmetric Badge
    Chapter 2 Correlation Between Preoperative Testing and Tumour Morphology in Acromegaly
  4. Altmetric Badge
    Chapter 3 Acromegaly: Objectives of Therapy
  5. Altmetric Badge
    Chapter 4 Surgical Treatment of Acromegaly
  6. Altmetric Badge
    Chapter 5 External Radiation Therapy of Acromegaly
  7. Altmetric Badge
    Chapter 6 Bromocriptine Treatment of Acromegaly
  8. Altmetric Badge
    Chapter 7 Chemical Structure, Pharmacodynamic Profile and Pharmacokinetics of SMS 201–995 (Sandostatin®)
  9. Altmetric Badge
    Chapter 8 Studies on the Acute and Chronic Effects of Sandostatin® in Acromegaly
  10. Altmetric Badge
    Chapter 9 Medical Treatment of Acromegaly. Dopaminergic Agonists and Long-Acting Somatostatin
  11. Altmetric Badge
    Chapter 10 Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995 (Sandostatin®)
  12. Altmetric Badge
    Chapter 11 Observations During a Clinical Trial of Sandostatin® in Acromegalic Patients
  13. Altmetric Badge
    Chapter 12 Effects of Long-Term Administration of Sandostatin® (SMS 201–995) at Increasing Doses in 40 Acromegalic Patients. Results from the French Sandostatin Acromegaly Study Group
  14. Altmetric Badge
    Chapter 13 Experience with Sandostatin® in Various Groups of Acromegalic Patients
  15. Altmetric Badge
    Chapter 14 Treatment of Acromegaly with SMS 201–995 (Sandostatin®): Clinical, Biochemical and Morphologic Study
  16. Altmetric Badge
    Chapter 15 Long-Term Treatment of Acromegaly by Continuous Subcutaneous Infusion of the Long-Acting Somatostatin Analog Sandostatin® (SMS 201–995, Octreotide)
  17. Altmetric Badge
    Chapter 16 Sandostatin® (SMS 201–995) Treatment of Acromegaly: Acute and Chronic Effects
  18. Altmetric Badge
    Chapter 17 Long-Term Efficacy of Sandostatin®(SMS 201–995, Octreotide) in 178 Acromegalic Patients. Results from the International Multicentre Acromegaly Study Group
  19. Altmetric Badge
    Chapter 18 Pulsatile Administration of SMS 201–995 (Sandostatin®) in the Treatment of Acromegaly
  20. Altmetric Badge
    Chapter 19 Treatment of Acromegaly with SMS 201–995 (Sandostatin®): A Collaborative Study in Japan
  21. Altmetric Badge
    Chapter 20 Long-Term Treatment of Resistant Acromegaly with a Somatostatin Analog (SMS 201–995, Sandostatin®)
  22. Altmetric Badge
    Chapter 21 High-Dose, Long-Term, Continuous Subcutaneous Infusion of SMS 201–995 (Sandostatin®) in Acromegaly
  23. Altmetric Badge
    Chapter 22 Long-Term Therapy of Acromegaly with SMS 201–995 (Sandostatin®)
  24. Altmetric Badge
    Chapter 23 Successful Treatment of Ophthalmoplegia in Acromegaly with the Somatostatin Analogue SMS 201–995 (Sandostatin®)
  25. Altmetric Badge
    Chapter 24 Sandostatin®(SMS 201–995) in the Treatment of Acromegaly
  26. Altmetric Badge
    Chapter 25 Somatostatin Octapeptide (SMS 201–995, Sandostatin®) in the Medical Treatment of Acromegaly
  27. Altmetric Badge
    Chapter 26 SMS 201–995 (Sandostatin®) Treatment of Therapy-Resistant Acromegaly
  28. Altmetric Badge
    Chapter 27 Sandostatin® (SMS 201–995) Can Exert a Direct Analgesic Effect
  29. Altmetric Badge
    Chapter 28 Relapsing Acromegaly Resistant to Both Bromocriptine and Sandostatin® Treatment
  30. Altmetric Badge
    Chapter 29 Consensus Discussion and Conclusions
Attention for Chapter 17: Long-Term Efficacy of Sandostatin®(SMS 201–995, Octreotide) in 178 Acromegalic Patients. Results from the International Multicentre Acromegaly Study Group
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
1 Mendeley
Summary Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Long-Term Efficacy of Sandostatin®(SMS 201–995, Octreotide) in 178 Acromegalic Patients. Results from the International Multicentre Acromegaly Study Group
Chapter number 17
Book title
Sandostatin® in the Treatment of Acromegaly
Published by
Springer, Berlin, Heidelberg, January 1988
DOI 10.1007/978-3-642-73694-0_17
Book ISBNs
978-3-64-273696-4, 978-3-64-273694-0
Authors

A. G. Harris, H. Prestele, K. Herold, V. Boerlin

View on publisher site
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 100%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 1 100%

This page is provided by Altmetric.